Healthletic Reports 33,500+ Global Customers As Research Focus Expands To Methylene Blue And Other Novel Compounds

(MENAFN- GlobeNewsWire - Nasdaq) U.S.-Based Supplement Company Integrates Findings from 230+ Scientific Studies to Guide Transparent Wellness Formulations

New York, June 06, 2025 (GLOBE NEWSWIRE) --

Healthletic, a U.S.-based nutritional supplement company dedicated to research-informed formulation, today announced it has surpassed 33,500 international customers. The company attributes this momentum to a commitment to transparency, scientific sourcing, and a growing portfolio of products developed around emerging compounds- including formulation research involving methylene blue .

With over 230 published studies reviewed during its product development process, Healthletic is exploring science-backed applications of lesser-known ingredients , such as methylene blue, in accordance with current regulatory and safety frameworks. These efforts are part of the company's broader mission to align wellness innovations with credible, published research rather than marketing-driven trends.

Healthletic's internal process includes comprehensive literature reviews, raw material verification, and third-party testing procedures. This method ensures consistency across formulations while fostering trust with health-conscious consumers seeking more transparent alternatives.

By developing products under U.S. regulatory oversight and emphasizing ingredient traceability, the company has expanded responsibly into select international markets. Healthletic's pipeline includes new formulations inspired by recent advancements in nutritional biochemistry, including further exploratory research into mitochondrial and cellular support pathways where compounds such as methylene blue are currently under study.

About Healthletic

Healthletic is a U.S.-based nutritional supplement company committed to transparent, research-aligned product development. Its approach is guided by over 230 peer-reviewed scientific studies, focusing on ingredient quality, regulatory compliance, and evolving nutritional science. Areas of current exploration include emerging compounds such as methylene blue, studied for their potential roles in human health. To learn more, visit

Media Contact
Healthletic
...

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

CONTACT: ...

MENAFN06062025004107003653ID1109647143